1. 200 AFFINITY: opicinumab in a targeted population of MS patients. Issue 12 (14th November 2019) Authors: Zhu, Bing; Calabresi, Peter A; Giovanonni, Gavin; Kapoor, Raj; Naismith, Robert; Hartung, Hans-Peter; Arnold, Douglas L; Wolstencroft, Paul; Johnson, Kristina Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: e50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Therapeutic protein–drug interaction assessment for daclizumab high‐yield process in patients with multiple sclerosis using a cocktail approach. (4th May 2016) Authors: Tran, Jonathan Q.; Othman, Ahmed A.; Wolstencroft, Paul; Elkins, Jacob Journal: British journal of clinical pharmacology Issue: Volume 82:Number 1(2016:Jul.) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗